Potential of Pegylated Interferon Alpha-2a in Behcet Uveitis: A Report of Five Cases

被引：16
|
作者：
Bielefeld, Philip [1 ]
Devilliers, Herve [1 ]
Deschasse, Clemence [2 ]
Saadoun, David [3 ]
Seve, Pascal [4 ]
Muselier, Aurore [1 ]
Creuzot-Garcher, Catherine [2 ]
Besancenot, Jean-Francois [1 ]
Bron, Alain Marie [2 ]
机构：
[1] Univ Hosp, Dept Internal Med & Syst Dis, 2 Blvd Marechal de Lattre de Tassigny,BP77908, F-21079 Dijon, France
[2] Univ Hosp, Dept Ophthalmol, Dijon, France
[3] Grp Hosp Pitie Salpetriere, Dept Internal Med 1, Paris, France
[4] Hop Croix Rousse, Hosp Civils Lyon, Dept Internal Med, Lyon, France
来源：
OCULAR IMMUNOLOGY AND INFLAMMATION | 2016年 / 24卷 / 05期
关键词：
LONG-TERM EFFICACY; THERAPY; DISEASE; SAFETY;
D O I：
10.3109/09273948.2015.1010652
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：599 / 602
页数：4
相关论文
共 50 条
  • [1] Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
    Lee, Ji Hwan
    Lee, Christopher Seungkyu
    Lee, Sung Chul
    BMC OPHTHALMOLOGY, 2018, 18
  • [2] Interferon Alpha-2a Therapy in Patients with Refractory Behcet Uveitis
    Hasanreisoglu, Murat
    Cubuk, Mehmet Ozgur
    Ozdek, Sengul
    Gurelik, Gokhan
    Aktas, Zeynep
    Hasanreisoglu, Berati
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (01) : 71 - 75
  • [3] Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behcet's Uveitis: Customizing Therapy according to the Clinical Features
    De Simone, Luca
    Invernizzi, Alessandro
    Aldigeri, Raffaella
    Mastrofilippo, Valentina
    Marvisi, Chiara
    Gozzi, Fabrizio
    Bolletta, Elena
    Adani, Chantal
    Pipitone, Nicolo
    Muratore, Francesco
    Fontana, Luigi
    Salvarani, Carlo
    Cimino, Luca
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (02) : 506 - 514
  • [4] The Results of Interferon-Alpha Treatment in Behcet Uveitis
    Eser-Ozturk, Hilal
    Sullu, Yuksel
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (03) : 498 - 504
  • [5] Safety and Effectiveness of Interferon Alpha-2a in Treatment of Patients with Behcet's Uveitis Refractory to Conventional Treatments
    Sobaci, Gungor
    Erdem, Uzeyir
    Durukan, A. Hakan
    Erdurman, Cuneyt
    Bayer, Atilla
    Koksal, Serkan
    Karagul, Suat
    Bayraktar, M. Zeki
    OPHTHALMOLOGY, 2010, 117 (07) : 1430 - 1435
  • [6] Cyclosporin A as an adjunct may enhance the therapeutic effect of interferon alpha-2a in patients with refractory Behcet's uveitis: a retrospective cohort study
    Yang, Peizeng
    Deng, Yang
    Zhang, Yinan
    Zhu, Yunyun
    Huang, Ziqian
    Dai, Lingyu
    Wu, Qiuying
    Su, Guannan
    Cao, Qingfeng
    Lai, Yujie
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2024, 15
  • [7] Factors Affecting Relapse and Remission in Behcet's Uveitis Treated with Interferon Alpha2a
    Celiker, Hande
    Kazokoglu, Haluk
    Direskeneli, Haner
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (01) : 58 - 65
  • [8] Results of Interferon Alpha-2a Therapy in Patients with Behcet's Disease
    Yalcindag, F. Nilufer
    Uzun, Aslihan
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (04) : 439 - 443
  • [9] Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behcet's Uveitis: A Small Case Series
    Celiker, Hande
    Kazokoglu, Haluk
    Direskeneli, Haner
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 15 - 22
  • [10] Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behcet's Uveitis: A Randomized Controlled Prospective Study
    Qian, Yujing
    Qu, Yi
    Gao, Fei
    Pei, Minghang
    Liang, Anyi
    Xiao, Junyan
    Zhao, Chan
    Zhang, Meifen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345